BlackRock Health Sciences Trust Asset Resilience Ratio

Latest as of December 2025: 0.86%

BlackRock Health Sciences Trust asset resilience ratio. BlackRock Health Sciences Trust (BME) has an Asset Resilience Ratio of 0.86% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BME defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$4.92 Million
Cash + Short-term Investments

Total Assets

$570.14 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of BlackRock Health Sciences Trust (2015–2025)

Asset resilience ratio of BlackRock Health Sciences Trust from 2015 to 2025. This chart shows how BlackRock Health Sciences Trust's Asset Resilience Ratio has changed over time. Read total liabilities of BlackRock Health Sciences Trust for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down BlackRock Health Sciences Trust's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BME current and non-current assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $4.92 Million 0.86%
Total Liquid Assets $4.92 Million 0.86%

Asset Resilience Insights

  • Limited Liquidity: BlackRock Health Sciences Trust maintains only 0.86% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

BlackRock Health Sciences Trust Industry Peers by Asset Resilience Ratio

Compare BlackRock Health Sciences Trust's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Bajaj Holdings & Investment Limited
NSE:BAJAJHLDNG
Asset Management 1.12%
IGM Financial Inc.
TO:IGM
Asset Management 12.70%
Groep Brussel Lambert NV
BR:GBLB
Asset Management 3.60%
Sprott Physical Gold and Silver Trust
TO:CEF
Asset Management 99.66%
Australian Foundation Investment Company Ltd
AU:AFI
Asset Management 0.01%
Golub Capital BDC Inc
NASDAQ:GBDC
Asset Management -96.41%
CI Financial Corp
TO:CIX
Asset Management 1.81%
Australian United Investment Company Ltd
AU:AUI
Asset Management 0.01%

BlackRock Health Sciences Trust Asset Resilience Ratio by Year (2015–2025)

BlackRock Health Sciences Trust asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for BlackRock Health Sciences Trust.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.86% $4.92 Million $570.14 Million -2.56pp
2024-12-31 3.42% $26.49 Million $774.59 Million -1.85pp
2023-12-31 5.27% $31.40 Million $596.10 Million +1.33pp
2022-12-31 3.94% $23.87 Million $606.13 Million -0.35pp
2021-12-31 4.28% $27.79 Million $648.81 Million +4.07pp
2019-12-31 0.22% $3.74 Million $1.73 Billion -7.09pp
2018-12-31 7.31% $25.97 Million $355.49 Million +3.00pp
2017-12-31 4.31% $14.42 Million $334.61 Million +1.12pp
2016-12-31 3.19% $8.74 Million $273.54 Million +0.25pp
2015-12-31 2.94% $8.85 Million $300.96 Million --
pp = percentage points

About BlackRock Health Sciences Trust

NYSE:BME USA Asset Management
Market Cap
$603.43 Million
Market Cap Rank
#11202 Global
#2930 in USA
Share Price
$46.69
Change (1 day)
-0.62%
52-Week Range
$37.67 - $46.98
All Time High
$46.98
About

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or d… Read more